An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment

Mise à jour : Il y a 4 ans
Référence : NCT00696995

Femme et Homme

  • | Pays :
  • Finland
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This study is conducted in Europe. The aim of this observational study is to evaluate the incidence of serious adverse drug reactions when initiating or switching to insulin therapy with NovoMix® 30 in subjects with type 2 diabetes under normal clinical practice conditions


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 2

Liens